Victoria L. Brown - 17 Jun 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Victoria Brown
Issuer symbol
APLS
Transactions as of
17 Jun 2022
Net transactions value
-$121,410
Form type
4
Filing time
22 Jun 2022, 16:26:16 UTC
Previous filing
29 Mar 2022
Next filing
28 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $121,410 -2,698 -9.7% $45.00 24,974 17 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 597 shares from the 04/30/22 ESPP purchase.